So the authors recommended myositis should be considered when MG patients had the features of elevated serum CK levels or stable muscle weakness unresponsive to acetylcholinesterase inhibitors (26), in particular for MG patients with thymoma (27). This evidence concerns the gene ACHE and myasthenia gravis.